(Q51493178)

5 April 2018

title

Multiple endocrine neoplasia type 1 (MEN 1) is associated with an increased prevalence of diabetes mellitus and impaired fasting glucose. (English)

1 reference

5 April 2018

multiple endocrine neoplasia

main subject

1 reference

based on heuristic

inferred from title

multiple endocrine neoplasia type 1

1 reference

3

1 reference

5 April 2018

author name string

Roland W McCallum

series ordinal

1

1 reference

5 April 2018

Venkat Parameswaran

series ordinal

2

1 reference

5 April 2018

publication date

1 August 2006

1 reference

5 April 2018

published in

Clinical Endocrinology

1 reference

5 April 2018

volume

65

1 reference

5 April 2018

issue

2

1 reference

5 April 2018

page(s)

163-168

1 reference

5 April 2018

Do patients with multiple endocrine neoplasia syndrome type 1 benefit from periodical screening?

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02563.X

Are patients with multiple endocrine neoplasia type I prone to premature death?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02563.X

Mortality in sporadic primary hyperparathyroidism: nationwide cohort study of multiple parathyroid gland disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02563.X

Patients with MEN-1 are more insulin-resistant than their non-affected relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02563.X

Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02563.X

The role of insulin and the adipocytokines in regulation of vascular endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02563.X

Enteropancreatic malignancy associated with multiple endocrine neoplasia type 1: risk factors and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02563.X

Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type I. An immunocytochemical study of nine patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02563.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02563.X

Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02563.X

Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02563.X

Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02563.X

Adrenal lesion in multiple endocrine neoplasia type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02563.X

Multiple endocrine neoplasia type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02563.X

10.1111/J.1365-2265.2006.02563.X

21 January 2018

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018